Free Trial
→ Satellite Images Spot Potential $10 Trillion Discovery (From Altimetry) (Ad)tc pixel
NYSEAMERICAN:AZTR

Azitra 5/12/2026 Earnings Report

Azitra logo
$0.24 0.00 (-0.53%)
As of 01:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Azitra EPS Results

Actual EPS
N/A
Consensus EPS
-$0.01
Beat/Miss
N/A
One Year Ago EPS
N/A

Azitra Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Azitra Announcement Details

Quarter
Date
5/12/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Azitra Earnings Headlines

Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program
May 6 at 8:00 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/azitra-inc-announces-new-us-patent-protecting-atr-12-program-302763513.html
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris
April 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/azitra-inc-announces-poster-presentation-at-asgct-2026-highlighting-atr-01-program-for-ichthyosis-vulgaris-302755095.html
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel
May 6 at 1:00 AM  |  American Alternative (Ad)
Azitra (AZTR) price target decreased by 50.00% to 1.38
March 27, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/azitra-aztr-price-target-decreased-by-50-00-to-1-38/ar-AA1ZxWDZ
This nano-cap pharma stock surged 80% days after a listing warning — what’s fueling the rally?
March 22, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/this-nano-cap-pharma-stock-surged-80-days-after-a-listing-warning-what-s-fueling-the-rally/ar-AA1Z410U
Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending
March 20, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/azitra-inc-aztr-surges-over-44-after-hours-here-s-why-it-s-trending/ar-AA1Z1PYW
See More Azitra Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Azitra? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Azitra and other key companies, straight to your email.

About Azitra

Azitra (NYSEAMERICAN:AZTR) Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance. By delivering live commensal organisms directly to affected skin regions, Azitra seeks to restore healthy barrier function and reduce inflammation without relying on conventional small-molecule or biologic drug approaches.

Founded in 2018, Azitra is traded on the NYSE American under the symbol AZTR. Its research and development operations combine microbiology, formulation science and translational dermatology, and the company’s clinical trials are conducted primarily in North America. Azitra has pursued collaborations with academic and medical centers to support its pipeline advancement.

Azitra’s leadership team brings together expertise in microbiome research, dermatology and pharmaceutical development, guiding the company toward regulatory milestones and strategic partnerships. With a mission to harness the therapeutic potential of the skin microbiome, Azitra aims to offer novel, targeted treatments for patients with chronic skin diseases.

View Azitra Profile
Earnings Tools